Name: CBIH Income Statement - Cannabis Bioscience International Holdings. Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CBIH - Cannabis Bioscience International Holdings. Inc.

USD | OTC Markets | Industrials

CBIH Income Statement - Cannabis Bioscience International Holdings. Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q3 FY 26	Q2 FY 26	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q3 FY 12	Q2 FY 12	Q1 FY 12	Q3 FY 11	Q2 FY 11	Q1 FY 11
Revenues
Revenues	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	-	0.1	0.1	-	8.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023
Revenues
Revenues	0.1	0.3	0.2	0.3
Cost of Revenue	0.0	0.0	0.0	0.1
Gross Profit	0.1	0.3	0.2	0.2
Operating Expenses
Research & Development	-	-	-	-
Selling General & Administrative	-	-	-	-
Selling & Marketing	-	-	-
Operating Income
Operating Income	(0.4)	(0.4)	(0.5)	(1.0)
Non-Operating
Interest Income	-	-	-	-
Interest Expense	0.1	0.1	0.2	0.1
Income From Equity Investments	-	-	-
Tax & Net
Income Tax Expense	-	-	0.0	0.0
Net Income From Continuing Ops	(0.5)	(0.5)	(0.7)	(1.0)
Net Income From Discontinued Ops	-	-	-
Per Share
EPS Basic	(0.00)	(0.00)	(0.00)	(0.00)
EPS Diluted	(0.00)	(0.00)	(0.00)	(0.00)
Shares Basic	11,626.7	10,716.4	10,317.6	9,001.5
Supplementary Data
EBITDA	-	-	-	-
EBIT	(0.4)	(0.4)	(0.5)	(1.0)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Income
Operating Income	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.2)	(0.1)	(0.2)	-	(0.3)	(0.2)	-	(1.0)	2.8	4.7	(1.6)	5.4	4.7

Tax & Net
Income Tax Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.3	0.9	1.3	0.3	0.2	0.4
Net Income From Continuing Ops	(0.1)	(0.1)	(0.1)	(0.2)	(0.2)	(0.1)	(0.1)	(0.1)	(0.2)	(0.1)	(0.2)	(0.3)	(0.3)	(0.2)	(0.2)	(1.3)	2.0
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	(0.1)	(0.1)	(0.1)	(0.2)	(0.2)	(0.1)	(0.1)	(0.1)	(0.2)	(0.1)	(0.2)	(0.3)	(0.3)	(0.2)	(0.2)	(1.3)	2.0
Net Income Attributable To Parent	(0.1)	(0.1)	(0.1)	(0.2)	(0.2)	(0.1)	(0.1)	(0.1)	(0.2)	(0.1)	(0.2)	(0.3)	(0.3)	(0.2)	(0.2)	(1.2)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	(0.1)	0.2	(0.3)
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	(0.1)	(0.1)	(0.1)	(0.2)	(0.2)	(0.1)	(0.1)	(0.1)	(0.2)	(0.1)	(0.2)	(0.3)	(0.3)	(0.2)	(0.2)

Supplementary Data
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.1	-	-	5.1
EBIT	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.2)	(0.1)	(0.2)	-	(0.3)	(0.2)	-	(1.0)	2.8	4.7	(1.6)

Per Share
EPS Basic	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00	0.00	-	-	-	-	-	-	-
EPS Diluted	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00	0.00	-	-	-	-
Shares Basic	11,626.7	11,626.7	11,626.7	-	10,726.5	10,497.5	10,458.9	-	10,372.4	10,331.7	10,331.7	-	7,858.5	8,090.5	-	-	-	-
Shares Diluted	11,626.7	11,626.7	11,626.7	-	10,726.5	10,497.5	10,458.9	-	10,372.4	10,331.7	10,331.7	-	7,858.5	8,090.5	-	-	-	-